Tony Ibrahim1, Lambros Tselikas2, Charbel Yazbeck3, Joseph Kattan4. 1. Hematology-Oncology Department, Faculty of Medicine-Saint Joseph University, Medical Sciences Campus, Alfred Naccach street, Ashrafie, Beirut, Lebanon. ibrahim_toni@hotmail.com. 2. Interventional Radiology, Gustave Roussy - Cancer Campus, Villejuif, France. 3. Gastroenterology-Hepatology Department, Faculty of Medicine-Holy Spirit Kaslik University, Kaslik, Lebanon. 4. Hematology-Oncology Department, Faculty of Medicine-Saint Joseph University, Beirut, Lebanon.
Abstract
BACKGROUND: Lung is the second most common site of colorectal cancer metastasis. Treatment is based mainly on systemic therapy which has largely evolved lately, but outcome remains relatively poor. The place of locoregional therapies as curative strategies is still debated. METHOD: A systematic literature review was performed by the authors for systemic therapy, surgery, radiofrequency ablation (RFA), and stereotactic body radiation therapy (SBRT). The highest level of evidence for each strategy was presented. Major findings were addressed in a summarized and clinically relevant manner. RESULTS: All reported studies were descriptive non comparative reports except for one retrospective study comparing surgery to SBRT. The highest level of evidence for each therapeutic strategy are presented as follows: three large meta-analyses for surgery as well as seven and three prospective trials for RFA and SBRT, respectively. DISCUSSION: Surgery has the highest level of evidence for cure followed by RFA and SBRT. However, careful patient selection and complete resection of all metastasis are the main principles behind the efficacy of local therapies in the curative setting. Despite encouraging results, randomized trials are still needed.
BACKGROUND: Lung is the second most common site of colorectal cancer metastasis. Treatment is based mainly on systemic therapy which has largely evolved lately, but outcome remains relatively poor. The place of locoregional therapies as curative strategies is still debated. METHOD: A systematic literature review was performed by the authors for systemic therapy, surgery, radiofrequency ablation (RFA), and stereotactic body radiation therapy (SBRT). The highest level of evidence for each strategy was presented. Major findings were addressed in a summarized and clinically relevant manner. RESULTS: All reported studies were descriptive non comparative reports except for one retrospective study comparing surgery to SBRT. The highest level of evidence for each therapeutic strategy are presented as follows: three large meta-analyses for surgery as well as seven and three prospective trials for RFA and SBRT, respectively. DISCUSSION: Surgery has the highest level of evidence for cure followed by RFA and SBRT. However, careful patient selection and complete resection of all metastasis are the main principles behind the efficacy of local therapies in the curative setting. Despite encouraging results, randomized trials are still needed.
Authors: Roel C J Schlijper; Janneke P C Grutters; Ruud Houben; Anne-Marie C Dingemans; Joachim E Wildberger; Dirk Van Raemdonck; Eric Van Cutsem; Karin Haustermans; Guido Lammering; Philippe Lambin; Dirk De Ruysscher Journal: Cancer Treat Rev Date: 2013-06-13 Impact factor: 12.111
Authors: U Pastorino; M Buyse; G Friedel; R J Ginsberg; P Girard; P Goldstraw; M Johnston; P McCormack; H Pass; J B Putnam Journal: J Thorac Cardiovasc Surg Date: 1997-01 Impact factor: 5.209
Authors: S Salah; K Watanabe; S Welter; J S Park; J W Park; J Zabaleta; F Ardissone; J Kim; M Riquet; K Nojiri; M Gisabella; S Y Kim; K Tanaka; B Al-Haj Ali Journal: Ann Oncol Date: 2012-04-29 Impact factor: 32.976
Authors: Tristan D Yan; Julie King; Adrian Sjarif; Derek Glenn; Karin Steinke; Ahmed Al-Kindy; David L Morris Journal: Ann Surg Oncol Date: 2007-02-07 Impact factor: 5.344
Authors: Samer Salah; Kazuhiro Watanabe; Joon Suk Park; Alaa Addasi; Ji Won Park; Jon Zabaleta; Francesco Ardissone; Jhingook Kim; Marc Riquet; Kazunori Nojiri; Mara Gisabella; Sun Young Kim; Kuniya Tanaka Journal: Ann Surg Oncol Date: 2013-01-20 Impact factor: 5.344
Authors: J F Regnard; D Grunenwald; L Spaggiari; P Girard; D Elias; M Ducreux; P Baldeyrou; P Levasseur Journal: Ann Thorac Surg Date: 1998-07 Impact factor: 4.330